In Jazz Pharms., Inc. v. Avadel CNS Pharms., LLC, the US Court of Appeals for the Federal Circuit held that the US District Court for the District of Delaware abused its discretion by issuing a permanent injunction conflicting with the Hatch-Waxman Act’s safe harbor and remedies provisions.
Source link
